Literature DB >> 3063497

Drug interactions that matter. A critical reappraisal.

G T McInnes1, M J Brodie.   

Abstract

Drug interactions are ubiquitous but those with proven clinical relevance are much less common. Only when the combined effects of the interacting drugs are greater or less than the arithmetic sum of their individual actions can the event be considered a true interaction. This eliminates many candidate 'interactions' which in reality merely describe the summation of similar or opposing, but independent, drug effects. An appreciation of those drug interactions that really do matter can be best achieved by combining a practical knowledge of the pharmacological mechanisms involved with awareness of the most vulnerable patients (those with little reserve capacity) and the drugs associated with the greatest risk (those with a narrow therapeutic index). This review follows these guidelines and provides an account of well documented drug interactions categorised according to mechanism.

Entities:  

Mesh:

Year:  1988        PMID: 3063497     DOI: 10.2165/00003495-198836010-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  304 in total

1.  Interaction between azapropazone and warfarin.

Authors:  J C McElnay; P F D'Arcy
Journal:  Br Med J       Date:  1977-09-17

2.  Chlormethiazole and alcohol: a lethal cocktail.

Authors:  G T McInnes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-07

3.  Amphetamine metabolism in amphetamine psychosis.

Authors:  E Anggård; L E Jönsson; A L Hogmark; L M Gunne
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

4.  Effect of diphenylhydantoin on cortisol kinetics in humans.

Authors:  Y Choi; K Thrasher; E E Werk; L J Sholiton; C Olinger
Journal:  J Pharmacol Exp Ther       Date:  1971-01       Impact factor: 4.030

5.  Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

6.  Cimetidine interaction with carbamazepine.

Authors:  N Telerman-Toppet; M E Duret; C Cöers
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

7.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.

Authors:  J Watkins; E C Abbott; C N Hensby; J Webster; C T Dollery
Journal:  Br Med J       Date:  1980-09-13

8.  The effect of zinc sulphate and of bicitropeptide on tetracycline absorption.

Authors:  R K Mapp; T J McCarthy
Journal:  S Afr Med J       Date:  1976-10-12

9.  Inhibition of theophylline metabolism by long-term allopurinol administration.

Authors:  R L Manfredi; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

10.  Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

View more
  23 in total

Review 1.  ["Clinically significant" new drug interactions].

Authors:  U Fuhr
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.

Authors:  D L Murdoch; G D Thomson; G G Thompson; G D Murray; M J Brodie; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

Review 3.  Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Authors:  Michael G Oefelein
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

Review 4.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 5.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 6.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

7.  Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant.

Authors:  Bente Glintborg; Stig Ejdrup Andersen; Kim Dalhoff
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

Review 8.  Drug interactions of clinical importance. An updated guide.

Authors:  D I Quinn; R O Day
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 9.  Polypharmacy: the cure becomes the disease.

Authors:  C A Colley; L M Lucas
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

Review 10.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.